Home

F__Zakowski_Maureen


Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib